Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indobufen versus aspirin for cerebral small vessel disease
ChiCTR2200055893Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Indobufen and aspirin in Cerebral Small Vessel Disease (CSVD) and ischemic stroke (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoints: Clinical symptom, Neuropsychological scale and 1 more. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
Indobufenaspirin
03
Conditions
Cerebral Small Vessel Disease (CSVD)ischemic stroke
Beyond the preview
Go deeper on ChiCTR2200055893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055893.